Clinical experience with beta adrenergic blocking agents in myocardial ischaemia: A dilemma and a challenge (Q40085188)

17 September 2017

1 reference

title

Clinical experience with beta adrenergic blocking agents in myocardial ischaemia: a dilemma and a challenge (English)

1 reference

17 September 2017

Clinical experience with beta adrenergic blocking agents in myocardial ischaemia: A dilemma and a challenge (English)

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

8 August 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

8 August 2023

author name string

N. S. Baber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6116243

8 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6116243

8 August 2023

publication date

1 January 1981

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0163725881900048?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

https://api.elsevier.com/content/article/PII:0163725881900048?httpAccept=text/plain

8 August 2023

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Pharmacology & Therapeutics

8 August 2023

published in

1 reference

17 September 2017

13

1 reference

17 September 2017

285-320

1 reference

17 September 2017

2

1 reference

Long-term treatment with ?-blockers after myocardial infarction

17 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Reduction of early ventricular arrhythmia by acebutolol in patients with acute myocardial infarction

8 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

The effects of practolol on the dysrhythmias complicating acute ischemic heart disease

8 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results

8 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Haemodynamic effects of beta-adrenergic blockade

8 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia

8 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Practolol in acute myocardial infarction

8 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Treatment of cardiac arrhythmias in unanesthetized patients. Role of adrenergic beta receptor blockade.

8 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Haemodynamic effects of propranolol (Inderal) in acute myocardial infarction.

8 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Properties of acebutolol in twenty patients with cardiac arrhythmias

8 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Alprenolol in acute myocardial infarction: Double-blind trial

8 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate.

8 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Absence of prophylactic effect of propranolol in myocardial infarction

8 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Antiarrhythmic therapy, ventricular premature depolarizations and sudden cardiac death: the tip of the iceberg

8 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man

8 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Plasma Propranolol Levels Associated with Suppression of Ventricular Ectopic Beats

8 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Intravenous and oral practolol in the acute stages of myocardial infarction

8 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease

8 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Propranolol in threatened myocardial infarction

8 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Long-term beta blockade: possible protection from myocardial infarction

8 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Prognostic significance of acute systolic hypertension after myocardial infarction

8 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials

8 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Propranolol in the Treatment and Prevention of Cardiac Arrhythmias

8 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Clinical use of I.C.I. 50172 as an antidysrhythmic agent in heart failure.

8 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

The use of beta-adrenergic receptor blocking drugs in dysrhythmias

8 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Haemodynamic effects of practolol

8 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Propranolol-induced reduction of signs of ischemic injury during acute myocardial infarction

8 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Improvement in prognosis of myocardial infarction by long-term beta-adrenoreceptor blockade using practolol. A multicentre international study

8 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report

8 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Management of acute myocardial infarction and accelerating angina

8 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Cardiac output after beta-adrenergic blockade in ischaemic heart disease

8 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Relationship between epicardial ST-segment elevation and myocardial ischemic damage after experimental coronary artery occlusion in dogs

8 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

The efficacy of antiarrhythmic agents during acute myocardial ischemia and the role of heart rate.

8 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Propranolol in persistent ventricular fibrillation complicating acute myocardial infarction

8 August 2023

47

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Relationship between epicardial ST-segment elevation, regional myocardial blood flow, and extent of myocardial infarction in awake dogs

8 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Reassessment of failed beta-blocker treatment in angina pectoris by peak-exercise heart rate measurements

8 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Practolol in the treatment of cardiac dysrhythmias due to acute myocardial infarction

8 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

The circulatory effects of Practolol (ICI 50172) in patients with acute myocardial infarction

8 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Special article. The role of beta-adrenergic blockade in myocardial infarction

8 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Early arrhythmias following experimental coronary occlusion in conscious dogs and their modification by beta-adrenoceptor blocking drugs

8 August 2023

57

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Management of arrhythmias in acute myocardial infarction

8 August 2023

58

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Alprenolol in the treatment of arrhythmias in acute coronary patients.

8 August 2023

59

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

The use of propranolol in arrhythmias complicating acute myocardial infarction

8 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Use of alprenolol in acute cardiac arrhythmias.

8 August 2023

63

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Evaluation of haemodynamic effects of intravenous propranolol at low dosage (1 and 2 mg) in acute myocardial infarction

8 August 2023

64

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers

8 August 2023

71

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Hemodynamic effects of the cardioselective beta-blocking agent metoprolol in acute myocardial infarction. A 24-hour catheterization study.

8 August 2023

72

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade

8 August 2023

73

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Comparative effects of propranolol and practolol in the early stages of experimental canine myocardial infarction

8 August 2023

74

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics

8 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

The role of propranolol in the treatment of acute myocardial infarction

8 August 2023

79

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Factors influenceing long-term prognosis in male patients surviving a first coronary attack

8 August 2023

81

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

The efficacy of sotalol in suppressing ventricular ectopic beats

8 August 2023

83

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Propranolol (Inderal) in cardiac arrhythmias

8 August 2023

85

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Trial of propranolol in acute myocardial infarction.

8 August 2023

86

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Failure of ST segment elevation to predict severity of acute myocardial infarction

8 August 2023

87

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Protective effect of propranolol in threatened myocardial infarction

8 August 2023

88

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Treatment of acute myocardial infarction with propranolol. Further studies on enzyme appearance and subsequent left ventricular function in treated and control patients with developing infarcts

8 August 2023

89

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Superiority of practolol versus propranolol in protection against ventricular fibrillation induced by coronary occlusion

8 August 2023

94

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

A CORONARY PROGNOSTIC INDEX FOR GRADING THE SEVERITY OF INFARCTION.

8 August 2023

95

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Reduction of enzyme levels by propranolol after acute myocardial infarction

8 August 2023

96

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

8 August 2023

97

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Increased Plasma Protein Binding of Propranolol and Chlorpromazine Mediated by Disease-Induced Elevations of Plasma α1Acid Glycoprotein

8 August 2023

98

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Cardiovascular and sympathetic response to exercise after long-term beta-adrenergic blockade

8 August 2023

99

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Haemodynamic effects of atenolol in patients with coronary artery disease

8 August 2023

100

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Effect of beta-blockers on arrhythmias during six weeks after suspected myocardial infarction

8 August 2023

101

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Population screening for myocardial ischemia

8 August 2023

102

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Ventricular Premature Beats and Mortality after Myocardial Infarction

8 August 2023

103

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Use of Oxprenolol in Cardiac Arrhythmias Associated with Acute Myocardial Ischaemia

8 August 2023

104

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Propranolol withdrawal syndrome - why?

8 August 2023

105

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

??-Adrenoceptor Blocking Drugs and Acute Myocardial Infarction1

8 August 2023

107

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

PROPRANOLOL (INDERAL) IN PERSISTENT VENTRICULAR FIBRILLATION

8 August 2023

108

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Beta-adrenergic blockade and cardiac arrhythmias

8 August 2023

109

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Effect of propranolol in myocardial infarction

8 August 2023

111

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Treatment of acute myocardial infarction with propranolol

8 August 2023

112

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Propranolol and threatened myocardial infarction

8 August 2023

113

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Haemodynamic effects of I.C.I. 50172 in patients with ischaemic heart disease

8 August 2023

114

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Compared incidence of first myocardial infarction in hypertensive patients under treatment containing propranolol or excluding beta-receptor blockade

8 August 2023

115

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Enzymatic indices of myocardial necrosis: influence on short- and long-term prognosis after myocardial infarction

8 August 2023

119

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Effects of propranolol on regional myocardial function, electrograms, and blood flow in conscious dogs with myocardial ischemia

8 August 2023

121

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Propranolol serum levels during twenty-four hours

8 August 2023

122

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Effects of age and cigarette smoking on propranolol disposition

8 August 2023

123

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Beta blockade with nadolol in patient with congestive heart-failure

8 August 2023

124

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Apex cardiogram and systolic time intervals in acute myocardial infarction and effects of practolol

8 August 2023

125

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

8 August 2023

126

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Double-blind study of the effect of cardioselective beta-blockade on chest pain in acute myocardial infarction

8 August 2023

127

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Metoprolol--a new cardioselective beta-adrenoceptor blocking agent for treatment of tachyarrhythmias

8 August 2023

128

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results

8 August 2023

129

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Heart failure complicating acute myocardial infarction

8 August 2023

130

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Value of electrocardiogram in predicting and estimating infarct size in man

8 August 2023

132

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial

8 August 2023

133

1 reference

https://api.crossref.org/works/10.1016/0163-7258(81)90004-8

8 August 2023

Identifiers

1 reference

17 September 2017

1 reference